Not recruitingISRCTN84658943
To tweet or not to tweet about schizophrenia
This study isn't currently recruiting.
In United KingdomSchizophreniaResearch study
Schizophrenia studies
Schizophrenia
Schizophrenia can affect how a person perceives reality, thinks and feels, sometimes involving hearing voices or holding unusual beliefs.
CompletedNCT06880328
18F-Dihydroxyphenylalanine (DOPA) Positron Emission Tomography (PET) Study to Explore Dopamine Synthesis Capacity in the Whole Striatum After 2 Weeks of Treatment With Ralmitaront or Placebo in people with Schizophrenia
Official study title
18F-Dihydroxyphenylalanine (DOPA) Positron Emission Tomography (PET), Randomized, Double-blind, Crossover Study to Explore Dopamine Synthesis Capacity in the Whole Striatum After 2 Weeks of Treatment With 150mg of RO6889450 or Placebo in Patients With Schizophrenia
This study has finished and is no longer accepting participants.
Multiple locations, including GlendaleSchizophreniaMedication studyAges 18–50
CompletedNCT01098110
Asenapine Compared to Placebo for schizophrenia
Official study title
A Multicenter, Randomized, Double-blind, Fixed-dose, 6-week Trial of the Efficacy and Safety of Asenapine Compared With Placebo in Subjects With an Acute Exacerbation of Schizophrenia (Phase 3)
This study has finished and is no longer accepting participants.
Location not clearly listedSchizophreniaMedication studyAges 20–64
CompletedNCT05486312
7-week Study With CT-155 in People With Schizophrenia
Official study title
A Multi-center, Exploratory, Single-Arm, 7-week Study to Evaluate the Feasibility and Acceptability of Treatment With CT-155 in People With Schizophrenia
This study has finished and is no longer accepting participants.
Multiple locations, including Culver CitySchizophreniaDevice studyAges 18–64
TerminatedNCT04742413
A 12-Month Observational Prospective Cohort Study to Analyze Cardiometabolic Profile Changes to Switch to Lurasidone in people with Schizophrenia. RESPECT Study.
Official study title
A 12-Month Observational Prospective Cohort Study to Analyze Cardiometabolic Profile Changes to Switch to Lurasidone in Patients With Schizophrenia. RESPECT Study.
This study ended early.
Multiple locations, including MálagaSchizophreniaObservational studyAges 18+
CompletedNCT04521868
A 6-month Study to Evaluate Sulforaphane Effects in Schizophrenia Patients
Official study title
A 6-month Study to Evaluate Sulforaphane add-on Effects in Treatment of Negative Symptoms and Cognition Impairment of Schizophrenia Patients
This study has finished and is no longer accepting participants.
In ChangshaSchizophreniaMedication studyAges 18–50
CompletedNCT03465787
Lurasidone HCL for schizophrenia
What is this study about?
Researchers compared Lurasidone HCL 160 mg and Quetiapine XR 600 mg to find out how the approaches affected psychotic symptoms in people with schizophrenia.
This study has finished and is no longer accepting participants.
In SeoulSchizophreniaMedication studyAges 19–75
UnknownNCT06515522
A Biological Signature for the Early Differential Diagnosis of Psychosis
Official study title
A Biological Signature for the Early Differential Diagnosis of Psychosis: Unveiling the Differences Between Mood Disorders and Schizophrenia With Multimodal Machine Learning Techniques
Current recruitment status is unconfirmed.
Location not clearly listedSchizophrenia, Depression, ...Observational studyAges 18–65
WithdrawnNCT05119894
A Clinical Pharmacology study of Brexpiprazole Long Acting Injectable (LAI) Administered as a Single Dose in people with Schizophrenia
Official study title
A Multicenter, Open-label, Clinical Pharmacology Trial to Determine the Pharmacokinetics, Tolerability, and Safety of Brexpiprazole Long Acting Injectable (LAI) Administered as a Single Dose in Patients With Schizophrenia
This study was withdrawn before enrollment.
Location not clearly listedSchizophreniaMedication studyAges 18–64
CompletedNCT05402111
A Clinical Study That Will Assess How Food Moves Through the Stomach and Effects Blood Glucose Levels in Subjects With Schizophrenia Taking SEP-363856 or and Prior Antipsychotic (PA) Standard
Official study title
A Randomized, Open-Label, Single Dose, Cross-over Study of Gastric Emptying Rate: SEP-363856 vs Prior Antipsychotic Standard of Care in Subjects With Schizophrenia
This study has finished and is no longer accepting participants.
Multiple locations, including Little RockSchizophreniaMedication studyAges 18–65
CompletedNCT05463770
A Clinical Study That Will Assess the Effect of SEP-363856 and Prior Antipsychotic (PA) Standard of Care on Glucose and Regulation of Insulin in people with Schizophrenia
Official study title
An Open-Label, Fixed Sequence, Multiple Dose Study of Glucose and Insulin Associated Parameters: SEP-363856 vs Prior Antipsychotic (PA) Standard of Care in Subjects With Schizophrenia Suffering From Metabolic Dysregulation
This study has finished and is no longer accepting participants.
Multiple locations, including Little RockSchizophreniaMedication studyAges 18–65
CompletedNCT05542264
A Clinical Study That Will Assess the Effect of SEP-363856 or Prior Antipsychotic (PA) Standard of Care on Body-weight Associated Parameters in Subjects With Schizophrenia
Official study title
A Double-Blind, Randomized, Multiple Dose Study of Weight Associated Parameters: SEP-363856 vs Prior Antipsychotic (PA) Standard of Care in Subjects With Schizophrenia Suffering From Metabolic Dysregulation
This study has finished and is no longer accepting participants.
Multiple locations, including Little RockSchizophreniaMedication studyAges 18–65
Registry coverage
We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.